Altered dynamics of T cell subsets in peripheral blood impacts disease progression in newly diagnosed multiple myeloma.

Mohini Vig, Lalit Kumar, Shweta Dubey, Ritu Gupta

Abstract read

In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohini VigAmity Institute of Virology & Immunology, Amity University Uttar Pradesh, Noida, India.

Lalit KumarLaboratory-Oncology, Dr B.R.A., IRCH, All India Institute of Medical Sciences, New Delhi, India.

Shweta DubeyAmity Institute of Virology & Immunology, Amity University Uttar Pradesh, Noida, India.

Ritu GuptaLaboratory-Oncology, Dr B.R.A., IRCH, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T cells are essential for tumor immunosurveillance and disease regulation in Multiple Myeloma (MM), but their role in disease pathogenesis is not well understood. To investigate this, we analyzed T cell subsets for activation status, relative distribution of naïve and memory T cell populations, regulatory T cells (Tregs), and circulating follicular helper T cells (cT

Indexed as

Cytotoxic T-cellsFollicular helper T-cellsHelper T-cellsNewly diagnosed multiple myelomaRegulatory T-cellsT-cell exhaustion

Identifiers

PMID40641743

DOI10.1016/j.bbrep.2025.102104

PMCPMC12242439

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.